NorthCoast Asset Management’s AstraZeneca AZN Stock Holding History

NorthCoast Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.78M	Buy	14,764 +1,358	+10%	+$158K	0.06%	190
2021 Q2	$1.61M	Sell	13,406 -240	-2%	-$26.3K	0.06%	204
2021 Q1	$1.36M	Sell	13,646 -28,461	-68%	-$2.86M	0.06%	204
2020 Q4	$4.21M	Buy	+42,107	New	+$4.46M	0.19%	99
2014 Q1	–	Sell	-36,274	Closed	-$2.15M	–	169
2013 Q4	$2.15M	Sell	36,274 -4,568	-11%	-$248K	0.14%	79
2013 Q3	$2.12M	Sell	40,842 -6,688	-14%	-$336K	0.14%	56
2013 Q2	$2.25M	Buy	+47,530	New	+$2.42M	0.17%	55

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

NorthCoast Asset Management's AZN Position: Q3 2021 in Review

NorthCoast Asset Management increased its AstraZeneca (AZN) stake by 10% in Q3 2021, buying an estimated $158K and bringing the position to 14,764 shares worth $1.78M. The position accounts for 0.06% of the portfolio, ranked #190.

NorthCoast Asset Management first reported a position in AZN in Q2 2013 and has held it in 7 quarters since. The position peaked at $4.21M in Q4 2020. 906 funds tracked by Wall St. Rank hold AZN as of Q3 2021.

NorthCoast Asset Management held 14,764 shares of AstraZeneca worth $1.78M as of Q3 2021.
NorthCoast Asset Management bought 1,358 AstraZeneca shares in Q3 2021, an estimated $158K.
AstraZeneca made up 0.06% of NorthCoast Asset Management's portfolio in Q3 2021, its #190 holding.
NorthCoast Asset Management first reported a position in AstraZeneca in Q2 2013 and has held it in 7 quarters since.
NorthCoast Asset Management's AstraZeneca position peaked at $4.21M in Q4 2020.
906 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2021.

Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.